The role of the capsule of the Streptococcus milleri group in its pathogenicity

Journal of Infection and Chemotherapy

Volumn 10, Issue 2, 2004, Pages 105-109

  Kanamori, Shuzo ^a   Kusano, Nobuchika ^b   Shinzato, Takashi ^a   Saito, Atsushi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Abscess; Capsule; Pathogenicity; Phagocytosis; Streptococcus milleri group

Indexed keywords

BACTERIAL PROTEIN; CELL MEMBRANE PROTEIN; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMPYEMA; LUNG ABSCESS; MALE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; SKIN ABSCESS; STREPTOCOCCUS CONSTELLATUS; STREPTOCOCCUS MILLERI;

EID: 2342588187     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-004-0305-7     Document Type: Article

References (22)

1. Gossling J. Occurrence and pathogenicity of the Streptococcus milleri group. Rev Infect Dis 1988;10:257-85.
2. Molina JM, Leport C, Bure A, Wolff M, Michon C, Vilde JL. Clinical and bacterial features of infections caused by Streptococcus milleri. Scand J Infect Dis 1991;23:659-66.
3. Piscitelli SC, Shwed J, Schreckenberger P, Danziger LH. Streptococcus milleri group: renewed interest in an elusive pathogen. Eur J Clin Microbiol Infect Dis 1992;11:491-8.
4. Ishida T, Hashimoto T, Arita M, Ito Isao, Osawa M. Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest 1998;114:1588-93.
5. Porta G, Rodriguez-Carballeira, Gomez L, Salavert M, Freixas N, Xercavins M, et al. Thoracic infection caused by Streptococcus milleri. Eur Respir J 1998;12:357-62.
6. Corredoira J, Casariego E, Moreno C, Villanueva MJ, Lopez Alvarez MJ, Varela J, et al. Prospective study of Streptococcus milleri hepatic abscess. Eur J Clin Microbiol Infect Dis 1998;17:556-60.
7. Brook I, Walker RI. The role of encapsulation in the pathogenesis of anaerobic Gram-positive cocci. Can J Microbiol 1985;31:176-80.
8. Toyoda K, Kusano K, Saito A. Pathogenicity of the Streptopcoccus milleri group in pulmonary infections: effect on phagocytic killing by human polymorphonuclear neutrophils. Kansenshogaku Zasshi 1995;69:308-15.
9. Okuda K, Takazoe I. Antiphagocytic effect of the capsular structure of a pathogenic strain of Bacteroides melaninogenicus. Bull Tokyo Dent Coll 1973;14:99-104.
10. Hendrickson DA, Krenz MM. Reagents and stains. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ, editors. Manual of clinical microbiology. 5th ed. Washington, DC: American Society for Microbiology; 1991. p. 1289-314.
11. Nakajima I. Polysaccharide. In: Migita S, Konda S, Honjo T, Hamaoka T, editors. Experimental manual for immunology. Tokyo: Nancodo; 1995. p. 193-7 (in Japanese).
12. Rotstein OD, Pruett TL, Fiegel VD, Nelson RD, Simmons RL. Succinic acid, a metabolic by-product of Bacteroides species, inhibits polymorphonuclear leukocyte function. Infect Immun 1985;48:402-8.
13. Onderdonk AB, Kasper DL, Cisneros RL, Bartlett JG. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated strains. J Infect Dis 1977;136:82-9.
14. Brook I, Gillmore JD, Coolbaugh JC, Walker RI. Pathogenicity of encapsulated Bacteroides melaninogenicus group, Bacteroides oralis and Bacteroides ruminicola in abscesses in mice. J Infect 1983;7:218-26.
15. Bottone EJ. Encapsulated Enterococcus faecalis: role of encapsulation in persistence in mouse peritoneum in absence of mouse lethality. Diagn Microbiol Infect Dis 1999;33:65-8.
16. Unworth PF. Hyaluronidase production in Streptococcus milleri in relation to infection. J Clin Pathol 1989;42:506-10.
17. Steffen EK, Hentges DJ. Hydrolytic enzymes of anaerobic bacteria isolated from human infections. J Clin Microbiol 1981;14:153-6.
18. Ruoff KL, Ferraro MJ. Hydrolytic enzymes of "Streptococcus milleri". J Clin Microbiol 1987;25:1645-7.
19. Jacob JA, Stobberingh EE. Hydrolytic enzymes of Streptococcus anginosus, and Streptococcus constellatus and Streptococcus intermedius in relation to infection. Eur J Clin Microbiol Infect Dis 1995;14:818-20.
20. Arala-Chaves MP, Higerd TB, Porto MT, Munoz J, Goust JM, Fudenberg HH, et al. Evidence for the synthesis and release of strongly immunosuppressive, noncytotoxic substances by Streptococcus intermedius. J Clin Invest 1979;64:871-83.
21. Shinzato T, Saito A. A mechanism of pathogenicity of "Streptococcus milleri group" in pulmonary infection: synergy with an anaerobe. J Med Microbiol 1994;40:118-23.
22. Wibawan IW, Pasaribu FH, Utama IH, Abdulmawjood A, Lammler C. The role of hyaluronic acid capsular material of Streptococcus equi subsp. zooepidemicus in mediating adherence to HeLa cells and in resisting phagocytosis. Res Vet Sci 1999;67:131-5.